Brugada syndrome.

Area of Science:

• Cardiology
• Genetics
• Electrophysiology

Background:

• Brugada syndrome, identified in 1992, is a significant cause of sudden cardiac death, predominantly affecting younger males.
• Patients may be symptomatic (syncope, palpitations) or asymptomatic.
• The condition is characterized by three distinct electrocardiographic patterns.

Purpose of the Study:

• To provide a comprehensive review of Brugada syndrome.
• To cover proposed mechanisms, epidemiology, clinical presentations, genetics, diagnosis, risk stratification, and treatment options.

Main Methods:

• This review synthesizes existing literature on Brugada syndrome.
• It examines diagnostic criteria, including electrocardiographic patterns and provocative drug testing.
• Risk stratification methods and current treatment strategies are discussed.

Main Results:

• Brugada syndrome is associated with a high risk of sudden cardiac death.
• Electrocardiographic patterns can be spontaneous or induced by sodium channel blockers.
• Risk stratification involves patient symptoms, ECG findings, family history, and electrophysiological studies.

Conclusions:

• The only effective treatment for Brugada syndrome to date is an implantable cardioverter defibrillator.
• Treatment decisions are guided by a thorough assessment of individual patient risk.
• Further research into mechanisms and novel therapies is warranted.